Aug 2026
Combining Type I&II Photosensitizer With Hypoxia-Activated Prodrug Enables Oxygen-Unrestricted Synergistic Photocatalytic Therapy.
This work provides an oxygen-unrestricted synergistic strategy to compensate for the limitations of standalone Type II PSs or HAPs monotherapy, offering valuable insights for clinical cancer treatment.
Haoran Hou, Hanhan Lu, Yingnan Wu et al.
· Small · 0 citations